110 related articles for article (PubMed ID: 26972301)
1. Potential Role of Placental Klotho in the Pathogenesis of Preeclampsia.
Cecati M; Giannubilo SR; Saccucci F; Sartini D; Ciavattini A; Emanuelli M; Tranquilli AL
Cell Biochem Biophys; 2016 Mar; 74(1):49-57. PubMed ID: 26972301
[TBL] [Abstract][Full Text] [Related]
2. The expression of heparanase in normal and preeclamptic placentas.
Ginath S; Lurie S; Golan A; Amsterdam A; Sandbank J; Sadan O; Kovo M
J Matern Fetal Neonatal Med; 2015 Sep; 28(13):1589-93. PubMed ID: 25189635
[TBL] [Abstract][Full Text] [Related]
3. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype.
Aggarwal PK; Jain V; Srinivasan R; Jha V
J Hypertens; 2009 Oct; 27(10):2044-50. PubMed ID: 19730395
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal-to-epithelial transition in the placental tissues of patients with preeclampsia.
Du L; Kuang L; He F; Tang W; Sun W; Chen D
Hypertens Res; 2017 Jan; 40(1):67-72. PubMed ID: 27511055
[TBL] [Abstract][Full Text] [Related]
5. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of PEG10 in human placentas from preeclamptic pregnancies.
Chen H; Sun M; Zhao G; Liu J; Gao W; Si S; Meng T
Acta Histochem; 2012 Oct; 114(6):589-93. PubMed ID: 22137777
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1.
Luo R; Shao X; Xu P; Liu Y; Wang Y; Zhao Y; Liu M; Ji L; Li YX; Chang C; Qiao J; Peng C; Wang YL
Hypertension; 2014 Oct; 64(4):839-45. PubMed ID: 24980667
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of survivin, the inhibitor of apoptosis protein correlates with severity of preeclampsia.
Li CF; Gou WL; Li XL; Wang SL; Yang T; Chen Q
Placenta; 2012 Jan; 33(1):47-51. PubMed ID: 22033156
[TBL] [Abstract][Full Text] [Related]
9. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: new insights into the role of this hormone in pregnancy.
Lanoix D; Guérin P; Vaillancourt C
J Pineal Res; 2012 Nov; 53(4):417-25. PubMed ID: 22686298
[TBL] [Abstract][Full Text] [Related]
10. Systemic and placental α-klotho: Effects of preeclampsia in the last trimester of gestation.
Loichinger MH; Towner D; Thompson KS; Ahn HJ; Bryant-Greenwood GD
Placenta; 2016 May; 41():53-61. PubMed ID: 27208408
[TBL] [Abstract][Full Text] [Related]
11. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.
Ota S; Miyamura H; Nishizawa H; Inagaki H; Inagaki A; Inuzuka H; Suzuki M; Miyazaki J; Sekiya T; Udagawa Y; Kurahashi H
Placenta; 2013 Dec; 34(12):1202-10. PubMed ID: 24140079
[TBL] [Abstract][Full Text] [Related]
12. PP035. Placental klotho protein in preeclampsia: A possible link to long term outcomes.
Giannubilo SR; Cecati M; Saccucci F; Corradetti A; Emanuelli M; A L Tranquilli
Pregnancy Hypertens; 2012 Jul; 2(3):260-1. PubMed ID: 26105357
[TBL] [Abstract][Full Text] [Related]
13. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism.
Makris A; Xu B; Yu B; Thornton C; Hennessy A
Placenta; 2006; 27(4-5):445-51. PubMed ID: 16026832
[TBL] [Abstract][Full Text] [Related]
14. Promoter Methylation Status of WNT2 in Placenta from Patients with Preeclampsia.
Liu Y; Ma Y
Med Sci Monit; 2017 Nov; 23():5294-5301. PubMed ID: 29109390
[TBL] [Abstract][Full Text] [Related]
15. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
Sun SG; Shen N; Zheng YH; Shang T
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
[TBL] [Abstract][Full Text] [Related]
16. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia.
Kim YJ; Park HS; Lee HY; Ha EH; Suh SH; Oh SK; Yoo HS
Placenta; 2006; 27(4-5):438-44. PubMed ID: 16009421
[TBL] [Abstract][Full Text] [Related]
17. 14-3-3 tau (YWHAQ) gene promoter hypermethylation in human placenta of preeclampsia.
Liu H; Tang Y; Liu X; Zhou Q; Xiao X; Lan F; Li X; Hu R; Xiong Y; Peng T
Placenta; 2014 Dec; 35(12):981-8. PubMed ID: 25305692
[TBL] [Abstract][Full Text] [Related]
18. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia.
Chelbi ST; Mondon F; Jammes H; Buffat C; Mignot TM; Tost J; Busato F; Gut I; Rebourcet R; Laissue P; Tsatsaris V; Goffinet F; Rigourd V; Carbonne B; Ferré F; Vaiman D
Hypertension; 2007 Jan; 49(1):76-83. PubMed ID: 17088445
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M as a target biological molecule of preeclampsia.
Lee G; Kil G; Kwon J; Kim S; Yoo J; Shin J
J Obstet Gynaecol Res; 2009 Oct; 35(5):869-75. PubMed ID: 20149034
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia.
Chedraui P; Andrade ME; Salazar-Pousada D; Escobar GS; Hidalgo L; Ramirez C; Spaanderman ME; Kramer BW; Gavilanes AW
Gynecol Endocrinol; 2015 Jul; 31(7):569-72. PubMed ID: 26036716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
